Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Kyverna Therapeutics (KYTX)  
$13.00 0.57 (4.59%) as of 4:30 Fri 5/24


Download
   
Exchange:
Security Type:
Shares Out: 43,000,000
Market Cap: 559.00(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $12.43 - $30.1
Level I Sector:
Level II Sector:
Level III Sector:

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 24.8
Insider 3/6 Months : 25.4
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 2,063,136 2,063,136 2,063,136
Total Buy Value $0 $45,388,992 $45,388,992 $45,388,992
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 4 4
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 16
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Vida Ventures Iii-A, L.p.   –       –       •   2024-02-12 4 B $22.00 $5,568,992 I/I 253,136 583 0.01 -57%     
   Vida Ventures Iii-A, L.p.   –       –       •   2024-02-12 4 A $0.00 $0 I/I 4,523,924 4,523,924     -
   Harper Sean E 10% Owner   –       –       •   2024-02-12 4 A $0.00 $0 I/I 4,523,924 735,984     -
   Bain Capital Life Sciences Opportunities Iii, Lp   –       –       •   2024-02-12 4 B $22.00 $9,900,000 I/I 450,000 3,163,868 0.01 -57%     
   Bain Capital Life Sciences Opportunities Iii, Lp   –       –       •   2024-02-12 4 A $0.00 $0 I/I 2,713,868 2,713,868     -
   Cohen Fred E   –       •       •   2024-02-12 4 A $0.00 $0 I/I 4,523,924 4,523,924     -
   Seidenberg Beth C   –       •       •   2024-02-12 4 A $0.00 $0 I/I 4,523,924 735,984     -
   Gilead Sciences Inc 10% Owner   –       –       •   2024-02-12 4 B $22.00 $20,020,000 D/D 910,000 4,126,119 2.45 -57%     
   Gilead Sciences Inc 10% Owner   –       –       •   2024-02-12 4 A $0.00 $0 D/D 3,216,119 3,216,119     -
   Rubin Michael P. Former 10% Owner   –       –      –    2024-02-12 4 B $22.00 $9,900,000 I/I 450,000 450,000 0.01 -57%     
   Rubin Michael P. Former 10% Owner   –       –      –    2024-02-12 4 A $0.00 $0 I/I 2,805,426 2,805,426     -
   Maag Peter Chief Executive Officer   •       •      –    2024-02-07 3 IO $0.00 $0 I/I 0 349,321     -
   Maag Peter Chief Executive Officer   •       •      –    2024-02-07 3 IO $0.00 $0 D/D 0 58,220     -
   Chung James Bum Chief Medical Officer   •       –      –    2024-02-07 3 IO $0.00 $0 D/D 0 65,918     -
   Jones Ryan Alexander Chief Financial Officer   •       –      –    2024-02-07 3 IO $0.00 $0 D/D 0 25,934     -
   Borie Dominique Christian See Remarks   •       –      –    2024-02-07 3 IO $0.00 $0 I/I 0 449,210     -

  16 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed